STREPTOMYCIN POISONING, RENAL DISEASE AND THE ARTIFICIAL KIDNEY

1958 ◽  
Vol 2 (23) ◽  
pp. 785-785 ◽  
Keyword(s):  
Renal Disease ◽  
Artificial Kidney

Rehabilitation in End-Stage Renal Disease

1975 ◽  
Vol 6 (2) ◽  
pp. 96-105
Author(s):  
Ebra George
Keyword(s):  
Renal Disease ◽  
Social Factors ◽  
End Stage Renal Disease ◽  
Artificial Kidney ◽  
Medical Problems ◽  
Stage Renal Disease ◽  
End Stage

The patient who is afflicted with end-stage renal disease presents a variety of considerations for those who participate in his rehabilitation. The artificial kidney, while necessary and successful, is at best a palliative solution to the medical problems only. There are numerous complications that may evolve from the utilization of the artificial kidney. It is not this paper's intention to elaborate on the medical aspects of the disease, but rather to elucidate the psycho-social factors inherent in the formulation 'and execution of a successful plan of total rehabilitation for the client presenting terminal uremia.

Technology Insight: innovative options for end-stage renal disease—from kidney refurbishment to artificial kidney

2007 ◽  
Vol 3 (10) ◽  
pp. 564-572 ◽  
Author(s):  
Branko Braam ◽  
Marianne C Verhaar ◽  
Peter Blankestijn ◽  
Walther H Boer ◽  
Jaap A Joles
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Artificial Kidney ◽  
Stage Renal Disease ◽  
End Stage

Heparin Neutralizing Activity in Patients with Renal Disease on Maintenance Haemodialysis

1978 ◽  
Vol 39 (03) ◽  
pp. 695-700 ◽  
Author(s):  
A Aronstam ◽  
B Dennis ◽  
M J Friesen ◽  
W F Clark ◽  
A L Linton ◽  
...  
Keyword(s):  
Renal Disease ◽  
Extracorporeal Circulation ◽  
Human Kidney ◽  
Artificial Kidney ◽  
Neutralizing Activity ◽  
Therapeutic Implications ◽  
Maintenance Haemodialysis ◽  
Dialysis Membranes ◽  
Stage Renal Disease ◽  
End Stage

SummaryHeparin neutralizing activity (HNA) was increased in plasma of patients with end-stage renal disease treated by maintenance haemodialysis. It was not raised in non-dialyzed patients with chronic renal failure, nor in patients with normal renal function who had been exposed to the extracorporeal circulation of the heart-lung bypass 48–72 hr before testing. It is postulated that the trauma of extracorporeal circulation causes platelets to release HNA which is not cleared by the dialysis membranes of the artificial kidney but is by the human kidney. This may have therapeutic implications for heparin dosage schedules during haemodialysis.

Design of a Portable Renal Replacement System Through Modeling and Experiment

2009 ◽  
Author(s):  
Jeffrey Olson ◽  
Jason Weaver ◽  
Yong Yang ◽  
David N. Ku ◽  
David W. Rosen
Keyword(s):  
United States ◽  
Renal Disease ◽  
Treatment Time ◽  
The United States ◽  
Artificial Kidney ◽  
Treatment Frequency ◽  
Hemodialysis Treatment ◽  
Wearable Artificial Kidney ◽  
Replacement System

There are approximately 65,000 patients on sustaining hemodialysis in the United States for renal disease. While hemodialysis is traditionally performed three times weekly, several studies have shown improved patient results with increased treatment frequency and shorter treatment time. A more portable hemodialysis treatment would represent an improvement over current treatments by giving patients the ability to dialyze at their convenience, and more often for shorter treatment times. A prototype wearable artificial kidney has been developed by Gura et al.

scholarly journals A wearable artificial kidney for patients with end-stage renal disease

JCI Insight ◽  
2016 ◽  
Vol 1 (8) ◽  
Author(s):  
Victor Gura ◽  
Matthew B. Rivara ◽  
Scott Bieber ◽  
Raj Munshi ◽  
Nancy Colobong Smith ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Artificial Kidney ◽  
Wearable Artificial Kidney ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Pumps in Wearable Ultrafiltration Devices: Pumps in Wuf Devices

2015 ◽  
Vol 39 (1-3) ◽  
pp. 115-124 ◽  
Author(s):  
Paolo Armignacco ◽  
Francesco Garzotto ◽  
Corrado Bellini ◽  
Mauro Neri ◽  
Anna Lorenzin ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Mechanical Action ◽  
Artificial Kidney ◽  
Dialysis Catheter ◽  
Pumping System ◽  
Blood Pumps ◽  
Wearable Artificial Kidney ◽  
Stage Renal Disease ◽  
End Stage

The wearable artificial kidney (WAK) is a device that is supposed to operate like a real kidney, which permits prolonged, frequent, and continuous dialysis treatments for patients with end-stage renal disease (ESRD). Its functioning is mainly related to its pumping system, as well as to its dialysate-generating and alarm/shutoff ones. A pump is defined as a device that moves fluids by mechanical action. In such a context, blood pumps pull blood from the access side of the dialysis catheter and return the blood at the same rate of flow. The main aim of this paper is to review the current literature on blood pumps, describing the way they have been functioning thus far and how they are being engineered, giving details about the most important parameters that define their quality, thus allowing the production of a radar comparative graph, and listing ideal pumps' features.

AUSDIAB * RENAL STUDY – EARLY INDICATORS OF RENAL DISEASE

Nephrology ◽  
2000 ◽  
Vol 5 (3) ◽  
pp. A93-A93
Author(s):  
Sj Chadban ◽  
P Kerr ◽  
E Briganti ◽  
D Dunstan ◽  
M De Courten ◽  
...  
Keyword(s):  
Renal Disease ◽  
Early Indicators
Sign in / Sign up

Export Citation Format

Share Document